Cite
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients::The MaxCmin trial
MLA
Dragsted, U. B., et al. Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1-Infected Patients::The MaxCmin Trial. Jan. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3062..18b4dd9a8cccb8872a87588240b28e8c&authtype=sso&custid=ns315887.
APA
Dragsted, U. B., Gerstoft, J., Pedersen, C., Peters, B., Duran, A., Obel, N., Castagna, A., Cahn, P., Clumeck, N., Bruun, J. N., Benetucci, J., Hill, A., Cassetti, I., Vernezza, P., Youle, M., Fox, Z., & Lundgren, J. D. (2003). Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients::The MaxCmin trial.
Chicago
Dragsted, U.B., J. Gerstoft, C. Pedersen, B. Peters, A. Duran, N. Obel, A. Castagna, et al. 2003. “Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1-Infected Patients::The MaxCmin Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3062..18b4dd9a8cccb8872a87588240b28e8c&authtype=sso&custid=ns315887.